Immunologic Function in the Elderly After Injury

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00447135
Recruitment Status : Completed
First Posted : March 14, 2007
Last Update Posted : January 30, 2008
Information provided by:
Summa Health System

Brief Summary:
The purpose of this research is to learn more about the function of the body's ability to fight infection when the immune response is activated when injury occurs, in the elderly population.

Condition or disease
Over the Age of 65 Admitted to the Trauma Service

  Show Detailed Description

Study Type : Observational
Actual Enrollment : 55 participants
Time Perspective: Retrospective
Official Title: Immunologic Function in the Elderly After Injury: the Polymorphonuclear Leukocyte (PMN) and Innate Immunity
Study Start Date : March 2005
Actual Primary Completion Date : December 2005
Actual Study Completion Date : December 2005

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   66 Years and older   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Elderly after injury

Inclusion Criteria:

  • Greater than 65
  • Admitted to the trauma service

Exclusion Criteria:

  • Inability to draw sufficient blood
  • Immunocompromised
  • Currently receiving systemic corticosteroids
  • Participation in other studies
  • In the opinion of the investigator will not be able to complete protocol

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00447135

United States, Ohio
Summa Health System
Akron, Ohio, United States, 44304
Sponsors and Collaborators
Summa Health System
Principal Investigator: William Fallon, MD Summa Health System

Responsible Party: Dr. William Fallon, Summa Health System Identifier: NCT00447135     History of Changes
Other Study ID Numbers: 04104
First Posted: March 14, 2007    Key Record Dates
Last Update Posted: January 30, 2008
Last Verified: January 2008

Keywords provided by Summa Health System:
Polymorphonuclear Leukocyte